#35 - Nir Barzilai, M.D.: How to tame aging

Mon, 07 Jan 2019 10:30:00 +0000

In this episode, Nir Barzilai, director of the Institute for Aging Research and expert in the genetics of longevity, discusses the evidence that metformin and rapamycin have anti-aging properties and how his TAME study aims to support this hypothesis in humans. Additionally, he describes the role of genetics in lifespan/healthspan and how it might affect important pathways such as IGF and insulin sensitivity.

We discuss:

Nir’s background and interest in aging and endocrinology [3:30];

History of metformin, and understanding the mechanism [11:15];

Attempting to define insulin resistance [21:15];

Metformin as a possible anti-aging drug [48:45];

The TAME trial: Targeting Aging with MEtformin [57:45];

Why Nir believes metformin can slow aging [1:16:30];

The genetic gift of centenarians [1:28:00];

IGF/GH and its impact on aging and chronic diseases [1:34:15];

Genetics/epigenetics of centenarians, gene sequencing, CETP-VV, Lp(a) [1:49:15];

Should you be taking HGH? [2:05:30];

NAD and NAD precursors (NR and NMN) [2:30:00];

Parting thoughts on metformin [2:36:15];

Possible blind spots in Nir and Peter’s thinking? [2:43:00]; and

More.

Learn more at www.PeterAttiaMD.com

Connect with Peter on Facebook | Twitter | Instagram.